Related Experiment Video
Updated: Jun 15, 2025
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report
A Gantner1, J B Hagemann2, B Grüner3
1Department of Internal Medicine III, University Hospital Ulm, Albert-Einstein-Allee 23, D-89081, Ulm, Germany. andrea.gantner@uniklinik-ulm.de.
Abstract:
In allogenic stem cell recipients, invasive fungal disease is a common yet dreaded complication with high mortality. Among these, fusariosis is especially complex to treat due to high intrinsic resistance and few antimycotic options, requiring close cooperation of all involved departments. We here report an instructive case of disseminated fusariosis after allogenic stem cell transplantation with fatal outcome despite maximum treatment.
Insights
Disseminated fusariosis is a dangerous complication in allogenic stem cell transplant patients. Despite maximal treatment, this case highlights the challenges and fatal outcome of invasive fungal disease.
Area of Science:
- Hematology
- Mycology
- Infectious Diseases
Background:
- Invasive fungal diseases (IFDs) are a significant cause of mortality in allogenic stem cell transplantation (aSCT).
- Fusariosis, a type of IFD, presents unique treatment challenges due to intrinsic antifungal resistance and limited therapeutic options.
Purpose of the Study:
- To report an instructive case of disseminated fusariosis following aSCT.
- To underscore the complexities in managing IFD in immunocompromised patients.
Main Methods:
- Case report detailing a patient with disseminated fusariosis post-aSCT.
- Review of treatment strategies and outcomes.
Main Results:
- The patient developed disseminated fusariosis after aSCT.
- Despite intensive and maximal therapeutic interventions, the outcome was fatal.
Conclusions:
- Fusariosis remains a critical and often untreatable complication in aSCT recipients.
- Effective management necessitates multidisciplinary collaboration and highlights the need for novel therapeutic strategies against resistant fungal pathogens.
